7月15日 - ** 制药公司Veradermics（MANE.N）的股价在盘前交易中上涨6.3%，至117.14美元
** 该公司表示，其试验性口服脱发药物VDPHL01在针对女性型脱发患者的中期研究中达到了主要目标；女性型脱发是一种常见病症，会导致头发逐渐变稀
** 据称，每日服用一次的受试者中有89%，每日服用两次的受试者中有90%报告称，经过六个月治疗后头发覆盖度有所改善
** 公司称，患者治疗区域内每平方厘米平均新增约23根头发
** 公司预计将于2027年上半年获得针对女性患者正在进行的中后期临床试验数据，并于2026年下半年获得针对男性患者的后期临床试验数据
** 根据最新收盘价计算，自该公司2月4日首次公开募股（IPO）以来，股价已上涨约12%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.